TC Biopharm (Holdings) Plc (TCBP)
USD 0.65
(38.59%)
USD 0.65
(38.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -10.54 Million | -15.29 Million | -5.58 Million | -3.43 Million | -6.72 Million |
| Net Income | -5.9 Million | -1.31 Million | -13.57 Million | -5.45 Million | -6.06 Million |
| Depreciation & Amortization | 819.56 Thousand | 959.04 Thousand | 1 Million | 1.07 Million | 904.46 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 444.45 Thousand | 1.12 Million | - | 804.71 Thousand | 835.79 Thousand |
| Change in working capital | -1.59 Million | -799.65 Thousand | -591.61 Thousand | 1.72 Million | 258.04 Thousand |
| Other non-cash items | -4.3 Million | -15.26 Million | 7.57 Million | -1.58 Million | -2.65 Million |
| Investing Cash Flow | -208.78 Thousand | -310.19 Thousand | -143.22 Thousand | -204.99 Thousand | -2.19 Million |
| Investments in PPE | -110.35 Thousand | -240.71 Thousand | -20.03 Thousand | -34.89 Thousand | -2.02 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -98.43 Thousand | -69.48 Thousand | -123.19 Thousand | -170.09 Thousand | -170.05 Thousand |
| Financing Cash Flow | 8.52 Million | 18.65 Million | 6.52 Million | 3.43 Million | 3.27 Million |
| Debt repayment | - | - | -122.46 Thousand | -415.27 Thousand | 135.53 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 4.18 Million | - | - | - | - |
| Other Financing Activities | 8.52 Million | 18.65 Million | 6.64 Million | 3.84 Million | 3.13 Million |
| Accounts receivables | -1.27 Million | -37.5 Thousand | -591.61 Thousand | 1.72 Million | 258.04 Thousand |
| Accounts payables | 2.27 Million | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | -323.71 Thousand | -762.15 Thousand | - | - | - |
| Cash at beginning of period | 4.8 Million | 1.56 Million | 748.01 Thousand | 956.49 Thousand | - |
| Cash at end of period | 2.46 Million | 4.8 Million | 1.56 Million | 748.01 Thousand | 956.49 Thousand |
| Capital Expenditure | -110.35 Thousand | -240.71 Thousand | -20.03 Thousand | -34.89 Thousand | -2.02 Million |
| Effect of forex changes on cash | -112.16 Thousand | 190.65 Thousand | 17.78 Thousand | -1891.00 | -61.92 Thousand |
| Net cash flow / Change in cash | -2.34 Million | 3.24 Million | 818.67 Thousand | -208.48 Thousand | 956.49 Thousand |
| Free Cash Flow | -10.65 Million | -15.53 Million | -5.6 Million | -3.46 Million | -8.75 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.32 Million | -3.13 Million | -5.9 Million | -3.13 Million | 224.51 Thousand | -634.91 Thousand |
| Depreciation & Amortization | 127.02 Thousand | 189.89 Thousand | 819.56 Thousand | 189.89 Thousand | 279.25 Thousand | 180.97 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 784.55 Thousand | 151.06 Thousand | 444.45 Thousand | 151.06 Thousand | 90.37 Thousand | 139.81 Thousand |
| Change in working capital | 102.26 Thousand | -953.86 Thousand | -1.59 Million | -953.86 Thousand | 196.04 Thousand | 289.78 Thousand |
| Other non-cash items | -100.58 Thousand | 1.74 Million | -4.3 Million | 1.74 Million | -4.95 Million | -2.88 Million |
| Investing Cash Flow | -5618.00 | 4018.00 | -208.78 Thousand | 4018.00 | -137.67 Thousand | -145.23 Thousand |
| Investments in PPE | -5618.00 | 24.25 Thousand | -110.35 Thousand | 24.25 Thousand | -100.87 Thousand | -120.18 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -5618.00 | -20.23 Thousand | -98.43 Thousand | -20.23 Thousand | -36.8 Thousand | -25.05 Thousand |
| Financing Cash Flow | 932.55 Thousand | 2.26 Million | 8.52 Million | 2.26 Million | 2.53 Million | 3.95 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 19.76 Thousand | - | - | - | - | - |
| Other Financing Activities | 932.55 Thousand | 2.26 Million | 8.52 Million | 2.26 Million | 2.53 Million | 3.95 Million |
| Accounts receivables | -110.74 Thousand | -792 Thousand | -1.27 Million | -792 Thousand | 196.04 Thousand | - |
| Accounts payables | 21.6 Thousand | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 102.26 Thousand | -161.85 Thousand | -323.71 Thousand | -161.85 Thousand | - | 289.78 Thousand |
| Cash at beginning of period | 2.46 Million | - | 4.8 Million | - | - | - |
| Cash at end of period | 980.95 Thousand | - | 2.46 Million | - | - | 5.7 Million |
| Capital Expenditure | -5618.00 | 24.25 Thousand | -110.35 Thousand | 24.25 Thousand | -100.87 Thousand | -120.18 Thousand |
| Effect of forex changes on cash | - | 3494.00 | -112.16 Thousand | 3494.00 | -75.66 Thousand | - |
| Net cash flow / Change in cash | -1.48 Million | - | -2.34 Million | - | - | 5.7 Million |
| Free Cash Flow | -2.41 Million | -1.97 Million | -10.65 Million | -1.97 Million | -4.26 Million | -3.03 Million |
1663
FRONTCAP
KARANWO
300471
HTOO
RRU